AZERUTAMIG

UNII:	7DGR11S93X
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	AZERUTAMIG
GSRS Full Record:	7DGR11S93X i

2920336-42-9
Azerutamig
DF-1001
DF1001
Heterodimeric multi-specific IgG1 antibody targeting human epidermal growth factor receptor 2 (HER2) and NKG2D on natural killer (NK) and cytotoxic T-cells
Immunoglobulin (H-gamma1_L-kappa)_scFvkh-H-gamma1(h-CH2-CH3), anti-[Homo sapiens KLRK1 (killer cell lectin like receptor K1, NKG2D, KLR, NKG2-D, CD314)] and anti-[Homo sapiens ERBB2 (epidermal growth factor receptor 2, receptor tyrosine-protein kinase erbB-2, EGFR2, HER2, HER-2, p185cerbB2, NEU, CD340)], Homo sapiens and humanized monoclonal antibody, bispecific
azerutamig [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

AZERUTAMIG

Synonyms and Mappings

Resources